Biotech firms race to recruit good bugs in war on cancer

11

(Reuters) – Biotech companies are competing to develop medicines using "bugs as drugs" to fight cancer, building on the latest scientific findings that patients with high levels of good gut bacteria are more likely to respond to modern immunotherapy.
Source : http://in.reuters.com/